Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer

Fig. 2

Screening out histone modification-related genes for constructing a risk signature. a PCA based on histone modification-related genes between normal pancreas and pancreatic cancer. b Volcano plot of histone modification-related DEGs in PC when compared with normal tissue. c Heatmap of histone modification-related DEGs between PC and normal tissue. d Log (Lambda) value of the 21 genes in LASSO regression analysis. e The most proper log (Lambda) value in LASSO regression analysis. f Four histone modification-related genes were screened out for constructing a risk signature

Back to article page